Position in INCY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$65,633,852
-$136,239,147 QoQ
Shares Held
578,986
-73.0% QoQ
Ownership
0.290%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#51
of 849 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. INCY ranks #4 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
This page
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,633,852 | 578,986 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $201,872,999 | 2,144,847 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $226,072,084 | 2,288,874 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $149,364,912 | 1,761,171 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $21,345,468 | 313,443 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $19,787,376 | 326,794 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $28,125,373 | 407,201 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $13,867,449 | 209,795 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $22,454,314 | 370,411 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $87,759,778 | 1,540,456 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $98,598,885 | 1,570,296 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $66,167,562 | 1,145,362 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $10,396,995 | 167,020 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $46,789,187 | 647,422 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $50,777,661 | 632,192 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $33,865,581 | 508,187 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $21,778,167 | 286,668 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $31,402,032 | 395,392 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $58,419,940 | 795,912 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,731,605 | 25,176 | Shares | Sole | 2021-11-08 | |
| 2021-03-31 | $1,375,332 | 16,923 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,743,601 | 20,046 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $2,900,307 | 32,319 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $18,941,566 | 182,183 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $77,982,993 | 1,064,905 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||